211 related articles for article (PubMed ID: 1383493)
1. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
McKenna KF; Baker GB; Coutts RT; Greenshaw AJ
J Pharm Sci; 1992 Aug; 81(8):832-5. PubMed ID: 1383493
[TBL] [Abstract][Full Text] [Related]
2. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels.
Griebel G; Curet O; Perrault G; Sanger DJ
Neuropharmacology; 1998 Jul; 37(7):927-35. PubMed ID: 9776388
[TBL] [Abstract][Full Text] [Related]
3. Chronic administration of the antidepressant phenelzine and its N-acetyl analogue: effects on GABAergic function.
McKenna KF; McManus DJ; Baker GB; Coutts RT
J Neural Transm Suppl; 1994; 41():115-22. PubMed ID: 7931216
[TBL] [Abstract][Full Text] [Related]
4. Tissue levels and some pharmacological properties of an acetylated metabolite of phenelzine in the rat.
Coutts RT; Mozayani A; Danielson TJ; Baker GB
J Pharm Sci; 1991 Aug; 80(8):765-7. PubMed ID: 1791538
[TBL] [Abstract][Full Text] [Related]
5. N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines.
McKenna KF; Baker GB; Coutts RT
Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):478-82. PubMed ID: 1881457
[TBL] [Abstract][Full Text] [Related]
6. Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine.
Parent MB; Habib MK; Baker GB
Biochem Pharmacol; 2000 May; 59(10):1253-63. PubMed ID: 10736426
[TBL] [Abstract][Full Text] [Related]
7. Recent studies on the MAO inhibitor phenelzine and its possible metabolites.
McKenna KF; Baker GB; Coutts RT; Rauw G; Mozayani A; Danielson TJ
J Neural Transm Suppl; 1990; 32():113-8. PubMed ID: 1982447
[TBL] [Abstract][Full Text] [Related]
8. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
Todd KG; Baker GB
J Affect Disord; 1995 Dec; 35(3):125-9. PubMed ID: 8749840
[TBL] [Abstract][Full Text] [Related]
9. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA.
Paslawski T; Treit D; Baker GB; George M; Coutts RT
Psychopharmacology (Berl); 1996 Sep; 127(1):19-24. PubMed ID: 8880939
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute and chronic phenelzine on regional monoamine metabolism in rats and its potentiation by deuterium substitution.
Juorio AV; Greenshaw AJ; Boulton AA
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):240-5. PubMed ID: 2429193
[TBL] [Abstract][Full Text] [Related]
11. Task-dependent effects of the antidepressant/antipanic drug phenelzine on memory.
Parent MB; Habib MK; Baker GB
Psychopharmacology (Berl); 1999 Mar; 142(3):280-8. PubMed ID: 10208320
[TBL] [Abstract][Full Text] [Related]
12. Effects of low-dose 4-fluorotranylcypromine on rat brain monoamine oxidase and neurotransmitter amines.
Sherry RL; Baker GB; Coutts RT
Biol Psychiatry; 1990 Sep; 28(6):539-43. PubMed ID: 1699613
[No Abstract] [Full Text] [Related]
13. Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular gamma-aminobutyric acid levels in the striatum.
Parent MB; Master S; Kashlub S; Baker GB
Biochem Pharmacol; 2002 Jan; 63(1):57-64. PubMed ID: 11754874
[TBL] [Abstract][Full Text] [Related]
14. Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice.
Bourin M; Hascoët M; Colombel MC; Coutts RT; Baker GB
J Psychiatry Neurosci; 2002 May; 27(3):178-85. PubMed ID: 12066447
[TBL] [Abstract][Full Text] [Related]
15. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration.
Urichuk LJ; Allison K; Holt A; Greenshaw AJ; Baker GB
J Affect Disord; 2000 May; 58(2):135-44. PubMed ID: 10781703
[TBL] [Abstract][Full Text] [Related]
16. The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain.
Davis JN; Carlsson A
J Neurochem; 1973 Oct; 21(4):783-90. PubMed ID: 4148239
[No Abstract] [Full Text] [Related]
17. Effects of the MAO inhibitor phenelzine on glutamine and GABA concentrations in rat brain.
Paslawski TM; Sloley BD; Baker GB
Prog Brain Res; 1995; 106():181-6. PubMed ID: 8584653
[TBL] [Abstract][Full Text] [Related]
18. Beta-adrenoceptors and antidepressants: possible 2-phenylethylamine mediation of chronic phenelzine effects.
McManus DJ; Mousseau DD; Paetsch PR; Wishart TB; Greenshaw AJ
Biol Psychiatry; 1991 Dec; 30(11):1122-30. PubMed ID: 1663791
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain.
Robinson DS; Campbell IC; Walker M; Statham NJ; Lovenberg W; Murphy DL
Neuropharmacology; 1979 Oct; 18(10):771-6. PubMed ID: 42024
[No Abstract] [Full Text] [Related]
20. Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin.
Todd KG; Baker GB
J Pharm Pharm Sci; 2008 May; 11(2):14s-21s. PubMed ID: 19203467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
